PPCB · Propanc Biopharma Inc. Common Stock
View on chartInsiders & Stakes
| Julian Norman Kenyon Director | ▲ Buy | Grant | 3,420,005 Shares held | 8/17/2021 | View profile |
| James Andrew Nathanielsz Chief Executive Officer | ▲ Buy | Grant | 2,800,000 Shares held | 8/17/2021 | View profile |
Transaction History
| Julian Norman Kenyon | ▲ Buy | Grant | 3,420,000 | $0 | 8/17/2021 |
| James Andrew Nathanielsz | ▲ Buy | Grant | 5,928,000 | $0 | 8/17/2021 |
| James Andrew Nathanielsz | ▲ Buy | Grant | 2,800,000 | $0 | 8/17/2021 |
| James Andrew Nathanielsz | ▼ Sell | Other | 33,259,350 | — | 2/4/2015 |
| Julian Norman Kenyon | ▼ Sell | Other | 17,654,470 | — | 2/4/2015 |
| James Andrew Nathanielsz | ▼ Sell | Open Market | 55,000 | $5K | 7/5/2013 |
| James Andrew Nathanielsz | ▼ Sell | Open Market | 15,000 | $3K | 1/23/2013 |
| James Andrew Nathanielsz | ▼ Sell | Open Market | 5,500 | $1K | 12/13/2012 |
| James Andrew Nathanielsz | ▼ Sell | Open Market | 5,000 | $1K | 9/14/2012 |
| James Andrew Nathanielsz | ▼ Sell | Open Market | 250,000 | $50K | 9/4/2012 |
| James Andrew Nathanielsz | ▲ Buy | Open Market | 250,000 | $50K | 8/23/2012 |